Biochim Biophys Acta (2000) 1488:119
For KPV, TB-500 and MOTS-c, FDA reported no human clinical evidence at all
Potential Benefits of AOD-9604 Fat Breakdown and Body Composition The core mechanism of AOD-9604 is dual: it stimulates lipolysis (the breakdown of stored fat into free fatty acids the body can use for energy) while simultaneously inhibiting lipogenesis (the conversion of excess calories into new fat stores)
[11] Use is not recommended in those who are allergic to cobalt or have Leber's disease
Full AI Image Prompt: Create a clean medical infographic titled GHK-Cu Claim Strength Matrix. Use a two-axis matrix with the horizontal axis labeled Evidence strength and the vertical axis labeled Claim scope. Place labeled cards: Topical skin aging, Wound-care context, Hair growth, Injectable regeneration, and Systemic anti-aging. Position topical skin aging and wound-care context closer to stronger evidence, hair growth in a limited or indirect evidence area, and injectable regeneration and systemic anti-aging in an uncertain evidence-gap area
Sermorelin requires 812 weeks for metabolic changes to become apparent, with maximum benefit taking 46 months